Quartus Capital Partners is Delighted to Announce the Final Closing of Quartus AI Fund LP with $50 Million Plus in Commitments
Notified -
Globe Newswire14-07-2025, 21:00
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept) 18-02-2025, 18:00
